Nicotinamide supplementation in diabetic nonalcoholic fatty liver disease patients: randomized controlled trial

BACKGROUND: Nicotinamide has been reported to protect against liver steatosis and metabolic imbalances in nonalcoholic fatty liver disease (NAFLD) in animal models. OBJECTIVES: The objective was to investigate the efficacy and safety of nicotinamide supplementation in diabetic NAFLD patients. DESIGN...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Kady, Rasha R., Ali, Amani K., El Wakeel, Lamia M., Sabri, Nagwa A., Shawki, May A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874180/
https://www.ncbi.nlm.nih.gov/pubmed/35222903
http://dx.doi.org/10.1177/20406223221077958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874180/
https://www.ncbi.nlm.nih.gov/pubmed/35222903
http://dx.doi.org/10.1177/20406223221077958

Ejemplares similares